Drug policies have traditionally sought to suppress supply and deter use through the application of punitive laws. Today, there is a growing recognition that these drug policies have not only failed to reach their objectives but have resulted in a great deal of collateral damage. Drug policy must be reformed to focus on health, human rights and development objectives, with the aim of making the market less harmful rather than necessarily reducing its size.
The intersessional meeting this autumn will focus on the expansion and diversification of drugs and drug markets, the historic rise of supply and demand, and the growing public health issues related to opioid use.
Civil society involvement in international processes is constantly growing: now is the time to build bridges, not only between movements, but between international institutions, to finally make drug policy a human rights issue.